Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Acanthosis nigricans

Dermatology · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 7 to 74% depending on age, origin, degree of obesity and associated endocrine disorder [1]

Gradual onset (obesity, insulin resistance)

Fasting sample.

Fasting laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Woman with hyperandrogenism or menstrual disorders (PCOS)

Fasting sample.

Fasting laboratory tests

Exclusion of other causes (diagnosis of PCOS)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Sudden, extensive or late-onset form: look for cancer

Tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (10)
  1. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014;5(3):239-49.
  2. Gillespie J, Roland-McGowan J, Diehl K, Latour E, et al. Is acanthosis nigricans a marker for metabolic syndrome? A systematic review. Am J Clin Dermatol. 2026;27(5):945-957.
  3. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1577 (HbA1c), 1802 (SDHEA), 0358 (SHBG), 7422 (insuline).
  4. Radu AM, Carsote M, Dumitrascu MC, Sandru F. Acanthosis nigricans: pointer of endocrine entities. Diagnostics (Basel). 2022;12(10):2519.
  5. Popa ML, Popa AC, Tanase C, Gheorghisan-Galateanu AA. Acanthosis nigricans: to be or not to be afraid. Oncol Lett. 2019;17(5):4133-4138.
  6. Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679.
  7. American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27-S49.
  8. National Institute for Health and Care Excellence (NICE). Type 2 diabetes: prevention in people at high risk. Public health guideline PH38, publiée le 12 juillet 2012, mise à jour le 15 septembre 2017 (recommandations sur l'évaluation du risque et les tests sanguins).
  9. US Preventive Services Task Force. Prediabetes and Type 2 Diabetes: Screening. Final Recommendation Statement, 24 août 2021 (recommandation B).
  10. Grob JJ, Rava MC, Gouvernet J, et al. The relation between seborrheic keratoses and malignant solid tumours. A case-control study. Acta Derm Venereol 1991;71(2):166-9.